Billionaire Klarman’s Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF Energy
The Baupost Group is a Boston-based hedge fund founded and operated by billionaire Seth Klarman.
Posts Tagged ‘Keryx Biopharmaceuticals Inc (KERX)’
Amgen, Inc. (AMGN), Impax Laboratories Inc (IPXL): Keryx Biopharmaceuticals (KERX)’s Stifel Conference Presentation
There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ:KERX) had to say at this week's Stifel Nicolaus Weisel Healthcare Conference in Boston.
Lexicon Pharmaceuticals, Inc. (LXRX), Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Why Clinical Trials Fail
Drugs fail their clinical trials for all kinds of reasons. Sometimes, it's related to efficacy; sometimes, it's safety related.
Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)’s Q2 Earnings
Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday.
ExOne Co (XONE), MannKind Corporation (MNKD): Here’s What This $30 Billion Pension Fund Has Been Buying
Today, let's look at the California State Teachers' Retirement System ("CalSTRS"), a major pension fund that's celebrating its 100th anniversary in 2013.
Solta Medical Inc (SLTM), Keryx Biopharmaceuticals (KERX): Two Stocks to Buy on Merger Speculation
Large healthcare companies are facing revenue declines due to expiring patents.
Keryx Biopharmaceuticals (KERX): Rare Diseases and Rare Drugs Could Mean Great Gains For You
The U.S. is the largest market of biotechnology products in the world.
Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry.
Liberty Media Corp (LMCA), Sarepta Therapeutics Inc (SRPT): Here’s What This $42 Billion Hedge Fund Company Has Been Buying
Shaw is known as a math wizard, and a quantitative investing pioneer. His firm is reportedly extremely selective, hiring less than 1% of applicants -- and Amazon.com, Inc.
Keryx Biopharmaceuticals (KERX), Dynavax Technologies Corporation (DVAX): Biotech Investing for Beginners
Huge fortunes are won and lost in the world of biotech nearly every week. For those new to this world, it can appear both alluring and scary.
Pharmacyclics, Inc. (PCYC), Keryx Biopharmaceuticals (KERX): These Cutting-Edge Science Stocks Are Soaring
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Sarepta Therapeutics Inc (SRPT), Keryx Biopharmaceuticals (KERX), MannKind Corporation (MNKD): Three Speculative Biotech Companies Primed to Pop
They don't have any products on the market. They have little or no revenue. Earnings? Nada. Many people are betting that they will fail.
Pitney Bowes Inc. (PBI), Cirrus Logic, Inc. (CRUS), Keryx Biopharmaceuticals (KERX): Here’s What This $3 Billion Market Wizard Has Been Buying
Today, let's look at Tudor Investment, founded in 1980 by Paul Tudor Jones and featuring the flagship Tudor BVI fund.
Amarin Corporation plc (ADR) (AMRN), Exelixis, Inc. (EXEL): Here’s What This 220% Gainer Has Been Buying and Selling
Today, let's look at Passport Capital, which was founded by John Burbank in 2000 and known for combining macroeconomic analysis and fundamental research.
3 Biotechs Still Burning Through Cash: Ariad Pharmaceuticals, Inc. (ARIA), Dynavax Technologies Corporation (DVAX), MannKind Corporation (MNKD)
Young, upstart pharmaceutical and biotech companies do one thing that almost no other industry does. They go years without generating any revenue.
Is Now The Time To Buy Keryx Biopharmaceuticals (KERX)?
Recently, Keryx Biopharmaceuticals (NASDAQ:KERX) achieved a new milestone as the company declared remarkable results from its Phase 3 trials of Zerenex.
Peregrine Pharmaceuticals (PPHM)’s Epic Failure (Maybe)
Clinical trial 101 says if a trial passes all of its primary endpoints it's successful. If it doesn't, it's not.
Xerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals (KERX)
Keryx Biopharmaceuticals (NASDAQ:KERX)’s latest kidney drug called Zerenex is a game changer for the company after achieving positive results from its long-term Phase 3 study...
3 Horrendous Health-Care Stocks This Week: Accuray Incorporated (ARAY), Keryx Biopharmaceuticals (KERX)
OraSure Technologies, Inc. (NASDAQ:OSUR) announced its fourth-quarter results after the market closed on Wednesday.
3 Stocks Laboring to Survive: Tellabs, Inc. (TLAB), Glu Mobile Inc. (GLUU) and More
The market had two ways to view Friday's employment numbers.
3 Biotechs Burning Through Cash: Keryx Biopharmaceuticals (KERX), Peregrine Pharmaceuticals (PPHM) and More
Young, upstart pharmaceutical and biotech companies do one thing that almost no other industry does. They go years without generating any revenue.
